Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports favorable ongoing efficacy results from the ...
Unsupported price hikes added $815 million to US drug spending in 2023
Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not ...